Jaguar Health adopts 1-year rights plan after receiving acquisition interest

Jaguar Health, Inc.

Board adopted limited-duration rights plan on Feb 26, 2025; expires Feb 26, 2026.
Rights trigger at 20% beneficial ownership of voting stock; holders can buy shares at $4.50 for twice the market value.
Jaguar received indication of interest to acquire the company; plan aims to discourage open-market accumulation without a premium.
First proof-of-concept IIT results for crofelemer in SBS-IF and MVID expected Q2 2025; FDA meeting on breast cancer subgroup results also Q2.
Record date for rights dividend is March 10, 2025.

item 1.01 item 3.03 item 5.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.